Khalid M Dousa

477 total citations
33 papers, 311 citations indexed

About

Khalid M Dousa is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Khalid M Dousa has authored 33 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 22 papers in Epidemiology and 7 papers in Organic Chemistry. Recurrent topics in Khalid M Dousa's work include Mycobacterium research and diagnosis (18 papers), Tuberculosis Research and Epidemiology (17 papers) and Quinazolinone synthesis and applications (7 papers). Khalid M Dousa is often cited by papers focused on Mycobacterium research and diagnosis (18 papers), Tuberculosis Research and Epidemiology (17 papers) and Quinazolinone synthesis and applications (7 papers). Khalid M Dousa collaborates with scholars based in United States, Qatar and Germany. Khalid M Dousa's co-authors include Robert A. Bonomo, Sebastian G. Kurz, Charles L. Daley, Barry N. Kreiswirth, Christopher R. Bethel, W. Henry Boom, John L. Johnson, Steven M. Holland, Magdalena A. Taracila and Hussam Al Soub and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Khalid M Dousa

29 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid M Dousa United States 12 195 189 54 45 41 33 311
Zoe Weiss United States 10 134 0.7× 165 0.9× 13 0.2× 26 0.6× 6 0.1× 24 278
Evelyne Le Roux France 9 214 1.1× 357 1.9× 15 0.3× 181 4.0× 44 1.1× 14 577
Hervé Dega France 9 118 0.6× 219 1.2× 18 0.3× 114 2.5× 11 0.3× 13 299
Keisuke Miki Japan 13 170 0.9× 261 1.4× 23 0.4× 91 2.0× 3 0.1× 57 554
Bartholomew R. Bono United States 4 49 0.3× 106 0.6× 14 0.3× 18 0.4× 14 0.3× 5 361
Masamichi Komiya Japan 10 37 0.2× 46 0.2× 6 0.1× 14 0.3× 39 1.0× 52 320
Catherine DeVoe United States 7 175 0.9× 89 0.5× 4 0.1× 7 0.2× 7 0.2× 13 275
Daniela Tacke Germany 8 264 1.4× 222 1.2× 7 0.1× 20 0.4× 2 0.0× 8 362
Xiaoju Lv China 9 96 0.5× 96 0.5× 4 0.1× 8 0.2× 10 0.2× 25 204
Luisa Durán Graeff Chile 8 169 0.9× 172 0.9× 9 0.2× 15 0.3× 2 0.0× 12 253

Countries citing papers authored by Khalid M Dousa

Since Specialization
Citations

This map shows the geographic impact of Khalid M Dousa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid M Dousa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid M Dousa more than expected).

Fields of papers citing papers by Khalid M Dousa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid M Dousa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid M Dousa. The network helps show where Khalid M Dousa may publish in the future.

Co-authorship network of co-authors of Khalid M Dousa

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid M Dousa. A scholar is included among the top collaborators of Khalid M Dousa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid M Dousa. Khalid M Dousa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dousa, Khalid M, Sebastian G. Kurz, Eric J. Rubin, et al.. (2025). The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus : From Laboratory Insights to Clinical Applications and the Case for Clinical Trials. Clinical Infectious Diseases. 82(1). e135–e145.
2.
3.
Dousa, Khalid M, Sebastian G. Kurz, Mark S. Plummer, et al.. (2024). Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus. mBio. 15(6). e0060924–e0060924. 10 indexed citations
4.
Dousa, Khalid M, et al.. (2024). Dual β-lactam for treatment of pulmonary Mycobacterium abscessus in a child. Antimicrobial Agents and Chemotherapy. 68(7). e0031924–e0031924. 6 indexed citations
5.
Dousa, Khalid M, et al.. (2024). The use of dual β-lactams to restore susceptibility of Mycobacterium avium complex. JAC-Antimicrobial Resistance. 6(5). dlae142–dlae142.
6.
Bethel, Christopher R., Magdalena A. Taracila, Qing Li, et al.. (2024). Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis. ACS Infectious Diseases. 10(5). 1767–1779. 2 indexed citations
7.
Dousa, Khalid M, Christopher R. Bethel, Sebastian G. Kurz, et al.. (2024). Durlobactam in combination with β-lactams to combat Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 69(2). e0117424–e0117424. 4 indexed citations
8.
Dousa, Khalid M, Hamad Abdel Hadi, Shahinaz Bedri, et al.. (2024). Health and humanitarian toll of Sudan's forgotten war. The Lancet. 404(10461). 1383–1385.
9.
Dousa, Khalid M, et al.. (2023). A 40-Year-Old Female With Mycobacterium abscessus Successfully Treated With a Dual Beta-Lactam Combination. Cureus. 15(6). e40993–e40993. 12 indexed citations
10.
Dousa, Khalid M, et al.. (2023). Eradicating Pulmonary Mycobacterium abscessus: The Promise of Dual β-Lactam Therapy. Open Forum Infectious Diseases. 10(6). ofad312–ofad312. 13 indexed citations
11.
Dousa, Khalid M, et al.. (2023). Containment of COVID-19 outbreak at a veterans affairs community living center. Journal of Infection Prevention. 24(3). 132–136. 1 indexed citations
12.
Dousa, Khalid M, Sebastian G. Kurz, Magdalena A. Taracila, et al.. (2022). Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action. mBio. 13(1). e0352921–e0352921. 30 indexed citations
13.
Mohamed, Mouhand, Shaikha D. Al-Shokri, Sara Mohamed, et al.. (2021). Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 7. 598846–598846. 30 indexed citations
14.
Bethel, Christopher R., Qing Li, Khalid M Dousa, et al.. (2021). 1390. Durlobactam, a Diazabicyclooctane (DBO) β-lactamase Inhibitor (BLI), Inhibits BlaC and Peptidoglycan (PG) Transpeptidases of Mycobacterium tuberculosis (Mtb): A Novel Approach to Therapeutics for Tuberculosis (TB)?. Open Forum Infectious Diseases. 8(Supplement_1). S780–S780. 2 indexed citations
15.
Dousa, Khalid M, et al.. (2020). SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis. IDCases. 20. e00778–e00778. 7 indexed citations
16.
Dousa, Khalid M, et al.. (2020). Drug-Resistant Tuberculosis. Infectious Disease Clinics of North America. 34(4). 863–886. 15 indexed citations
17.
Redmond, Sarah N., Khalid M Dousa, Jennifer L. Cadnum, et al.. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid contamination of surfaces on a coronavirus disease 2019 (COVID-19) ward and intensive care unit. Infection Control and Hospital Epidemiology. 42(2). 215–217. 13 indexed citations
18.
Hadi, Hamad Abdel, Muna Almaslamani, Nahla O. Eltai, et al.. (2019). Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar. Journal of Antimicrobial Chemotherapy. 74(12). 3497–3504. 26 indexed citations
19.
Dousa, Khalid M, et al.. (2018). Renal infarction in vascular Ehlers–Danlos syndrome masquerading as pyelonephritis. Clinical Case Reports. 6(8). 1478–1480. 3 indexed citations
20.
El‐Menyar, Ayman, et al.. (2012). Low Vitamin D and Cardiovascular Risk Factors in Males and Females from a Sunny, Rich Country. The Open Cardiovascular Medicine Journal. 6(1). 76–80. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zoe Weiss Breakdown of academic impact, for papers by Evelyne Le Roux Breakdown of academic impact, for papers by Hervé Dega Breakdown of academic impact, for papers by Keisuke Miki Breakdown of academic impact, for papers by Bartholomew R. Bono Breakdown of academic impact, for papers by Masamichi Komiya Breakdown of academic impact, for papers by Catherine DeVoe Breakdown of academic impact, for papers by Daniela Tacke Breakdown of academic impact, for papers by Xiaoju Lv Breakdown of academic impact, for papers by Luisa Durán Graeff
Rankless by CCL
2026